PATENT CLAIM ANALYSIS

Application Number: 16202637
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "304000"]

Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific doses of tropifexor, in particular for treating or preventing liver diseases.

Claim (Index 3):
The method according to  claim 1 , wherein the dose is a daily dose.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.07143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16030141', '11081002', '15139138', '15299559', '16335662']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7978441161717635
- 35 USC 102 Novelty (BERT): 0.5229012556004338
- Combined Prediction Score: 0.7703498301146307
- Mean Citation Score: 321.56227
- Max Citation Score: 330.3247
- Similarity Product: 252.23869465490583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test